AKT1 and breast neoplasm: In this study, we performed RTK arrays and RNA sequencing on different breast tumor lines with prolonged treatment of ATP-competitive or allosteric Akt inhibitors, with the goal of utilizing unbiased platforms to delineate pathways and proteins associated with acquired resistance.